Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2025 15:00 ET | Source: Dyadic International, Inc.

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

JUPITER, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient...
March 26, 2025 16:05 ET | Source: Dyadic International, Inc.

Dyadic Reports 2024 Year-End Financial Results and Business Updates

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 million in grants awarded from CEPI and Gates Foundation intended to...
November 12, 2024 16:05 ET | Source: Dyadic International, Inc.

Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets

Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms Alternative Proteins Demonstrated substantial revenue...
June 05, 2023 09:39 ET | Source: Persistence Market Research

Recombinant Cell Culture Supplements Market Booms with a Projected Market Value of US$ 947.7 million by 2033 - Persistence Market Research

New York, June 05, 2023 (GLOBE NEWSWIRE) -- The global recombinant cell culture supplements market size was valued at US$ 495.5 million in 2022 and is projected to reach US$ 947.7 million by 2033,...